BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21344355)

  • 21. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
    J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Localisation of hepatic lesions to liver segments according to sonography (US), computed tomography (CT) and surgery (OP): a comparative study].
    Schacherer D; Decking D; Herold T; Obed A; Schlitt HJ; Gruene S; Schoelmerich J; Schlottmann K
    Z Gastroenterol; 2010 Feb; 48(2):241-5. PubMed ID: 20127599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
    Okamura N; Yoshida M; Shibuya A; Sugiura H; Okayasu I; Ohbu M
    Pathol Int; 2005 Nov; 55(11):724-31. PubMed ID: 16271085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CT and MR imaging differences between intrahepatic cholangiocarcinoma and hepatocellular carcinoma with invasions to billary tracts].
    Yang NJ; Song B; Wu B; Xu J; Zhao LM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):525-8. PubMed ID: 19627020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma.
    Ryu HS; Lee K; Shin E; Kim SH; Jing J; Jung HY; Lee H; Jang JJ
    Tumori; 2012; 98(4):478-84. PubMed ID: 23052165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
    Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
    J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
    Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
    Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic study on cholangiolocellular carcinoma.
    Shiota K; Taguchi J; Nakashima O; Nakashima M; Kojiro M
    Oncol Rep; 2001; 8(2):263-8. PubMed ID: 11182037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraductal Hepatocellular Carcinoma without Parenchymal Tumor: A Case Report.
    Ramakrishna B; Shah GJ; Vyas F
    J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S77-9. PubMed ID: 21814761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined hepatocellular-cholangiocarcinoma. Cytologic findings in four cases.
    Dusenbery D
    Acta Cytol; 1997; 41(3):903-9. PubMed ID: 9167724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Independent occurrence of hepatocellular and cholangiocellular cancer nodules in the liver.
    Furuta T; Kanematsu T; Sonoda T; Sugimachi K
    Eur J Surg Oncol; 1987 Feb; 13(1):69-73. PubMed ID: 3028868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined hepatocellular and cholangiocarcinoma with marked squamous cell carcinoma components arising in non-cirrhotic liver.
    Tsuneyama K; Kaizaki Y; Doden K; Kidani E; Harada K; Sasaki M; Nakanuma Y
    Pathol Int; 2003 Feb; 53(2):90-7. PubMed ID: 12588436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic value of absent ductular reaction at hepatocellular-stromal boundaries in early stage hepatocellular carcinoma].
    Zhang Q; Ma Z; Xin Q; Liu GQ; Liu BB; Gao YT; Zhang CS; Du Z
    Zhonghua Gan Zang Bing Za Zhi; 2013 Dec; 21(12):924-8. PubMed ID: 24636295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synchronous carcinoma of the gallbladder in a patient with intrahepatic bile duct carcinoma.
    Taniai N; Onda M; Tajiri T; Yoshida H; Naitou Z
    Hepatogastroenterology; 2000; 47(31):121-4. PubMed ID: 10690592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sarcomatous cholangiocarcinoma.
    Gupta K; Powari M; Dey P
    Diagn Cytopathol; 2003 Mar; 28(3):168-9. PubMed ID: 12619101
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful diagnosis and resection of icteric type hepatocellular carcinoma.
    Murakami Y; Yokoyama T; Kanehiro T; Uemura K; Sasaki M; Morifuji M; Sueda T
    Hepatogastroenterology; 2003; 50(53):1634-6. PubMed ID: 14571803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A resected case of combined hepatocellular carcinoma and cholangiocarcinoma associated with cystic formation.
    Utsunomiya T; Saitsu H; Saku M; Takeshita M; Yoshida K; Kajiyama K; Sugimachi K
    Hepatogastroenterology; 2000; 47(33):851-4. PubMed ID: 10919046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrahepatic cholangiocarcinoma detected by elevated levels of alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma in a patient with Budd-Chiari syndrome.
    Yamamoto M; Otsubo T; Ariizumi S; Nakano M; Takasaki K
    Int Surg; 2005; 90(2):81-4. PubMed ID: 16119710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.